Intrathecal administration of roscovitine prevents remifentanil-induced postoperative hyperalgesia and decreases the phosphorylation of N-methyl-d-aspartate receptor and metabotropic glutamate receptor 5 in spinal cord

Bibb, 2003, Role of Cdk5 in neuronal signaling, plasticity, and drug abuse, Neurosignals, 12, 191, 10.1159/000074620 Blaabjerg, 2001, The metabotropic glutamate receptor agonist 1S,3R-ACPD stimulates and modulates NMDA receptor mediated excitotoxicity in organotypic hippocampal slice cultures, Brain Res., 898, 91, 10.1016/S0006-8993(01)02148-5 Bogen, 2008, GDNF hyperalgesia is mediated by PLCγ, MAPK/ERK, PI3K CDK5 and Src family kinase signaling and dependent on the IB4-binding protein versican, Eur. J. Neurosci., 28, 12, 10.1111/j.1460-9568.2008.06308.x Brennan, 1996, Characterization of a rat model of incisional pain, Pain, 64, 493, 10.1016/0304-3959(95)01441-1 Chang, 2011, Cyclophosphamide induces NR2B phosphorylation-dependent facilitation on spinal reflex potentiation, Am. J. Physiol. Renal Physiol., 300, F692, 10.1152/ajprenal.00531.2010 Chaplan, 1994, Quantitative assessment of tactile allodynia in the rat paw, J. Neurosci. Methods, 53, 55, 10.1016/0165-0270(94)90144-9 Chen, 2011, Elevation of p-NR2A(S1232) by Cdk5/p35 contributes to retinal ganglion cell apoptosis in a rat experimental glaucoma model, Neurobiol. Dis., 43, 455, 10.1016/j.nbd.2011.04.019 Cheung, 2006, Synaptic roles of Cdk5: implications in higher cognitive functions and neurodegenerative diseases, Neuron, 50, 13, 10.1016/j.neuron.2006.02.024 Dolan, 2003, Up-regulation of metabotropic glutamate receptor subtypes 3 and 5 in spinal cord in a clinical model of persistent inflammation and hyperalgesia, Pain, 106, 501, 10.1016/j.pain.2003.09.017 Gabra, 2008, mGluR5 antagonists that block calcium mobilization in vitro also riverse (S)-3,5-DHPG induced hyperalgesia and morphine antinociceptive tolerance in vivo, Brain Res., 1187, 58, 10.1016/j.brainres.2007.10.007 Gu, 2009, Tyrosine phosphorylation of the N-methyl-d-aspartate receptor 2B subunit in spinal cord contributes to remifentanil-induced postoperative hyperalgesia: the preventive effect of ketamine, Mol. Pain, 5, 76, 10.1186/1744-8069-5-76 Guignard, 2002, Supplementing desflurane-remifentanil anesthesia with small-dose ketamine reduces perioperative opioid analgesic requirements, Anesth. Analg., 95, 103, 10.1097/00000539-200207000-00018 Guntz, 2005, Effects of remifentanil on N-methyl-d-aspartate receptor: an electrophysiolosic study in rat spinal cord, Anesthesiology, 102, 1235, 10.1097/00000542-200506000-00025 Guo, 2004, Group I metabotropic glutamate receptor NMDA receptor coupling and signaling cascade mediate spinal dorsal horn NMDA receptor 2B tyrosine phosphorylation associated with inflammatory hyperalgesia, J. Neurosci., 24, 9161, 10.1523/JNEUROSCI.3422-04.2004 Hargreaves, 1988, A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia, Pain, 32, 77, 10.1016/0304-3959(88)90026-7 Hawasli, 2007, Cyclin dependent kinase 5 governs learning and synaptic plasticity via control of NMDAR degradation, Nat. Neurosci., 10, 880, 10.1038/nn1914 Joly, 2005, Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine, Anesthesiology, 103, 147, 10.1097/00000542-200507000-00022 Kinney, 2005, A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models, J. Pharmacol. Exp. Ther., 313, 199, 10.1124/jpet.104.079244 Komatsu, 2007, Remifentanil for general anaesthesia: a systematic review, Anaesthesia, 62, 1266, 10.1111/j.1365-2044.2007.05221.x Lee, 2006, Synaptic plasticity and phosphorylation, Pharmacol. Ther., 112, 810, 10.1016/j.pharmthera.2006.06.003 Lenz, 2011, Effects of COX inhibition on experimental pain and hyperalgesia during and after remifentanil infusion in humans, Pain, 152, 1289, 10.1016/j.pain.2011.02.007 Li, 2001, Regulation of NMDA receptors by cyclin-dependent kinase-5, Proc. Natl. Acad. Sci. U S A, 98, 12742, 10.1073/pnas.211428098 Li, 2000, Integrin alpha(1) beta(1)-mediated activation of cyclin-dependent kinase 5 activity is involved in neurite outgrowth and human neurofilament protein H Lys-Ser-Pro tail domain phosphorylation, J. Neurosci., 20, 6055, 10.1523/JNEUROSCI.20-16-06055.2000 Liu, 2001, Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors, Proc. Natl. Acad. Sci. U S A, 98, 11062, 10.1073/pnas.191353898 Mao, 2002, Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy, Pain, 100, 213, 10.1016/S0304-3959(02)00422-0 Meijer, 1997, Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5, Eur. J. Biochem., 243, 527, 10.1111/j.1432-1033.1997.t01-2-00527.x Moghaddam, 2004, Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia, Psychopharmacology (Berl.), 174, 39, 10.1007/s00213-004-1792-z Mori, 1995, Structure and function of the NMDA receptor channel, Neuropharmacology, 34, 1219, 10.1016/0028-3908(95)00109-J Nakazawa, 2001, Characterization of Fyn-mediated tyrosine phosphorylation sites on GluR epsilon 2 (NR2B) subunit of the N-methyl-d-aspartate receptor, J. Biol. Chem., 276, 693, 10.1074/jbc.M008085200 Orlando, 2009, Phosphorylation of the homer-binding domain of group I metabotropic glutamate receptor by cyclin-dependent kinase 5, J. Neurochem., 110, 557, 10.1111/j.1471-4159.2009.06139.x Paglini, 1998, Evidence for the participation of the neuron-specific CDK5 activator p35 during laminin-enhanced axonal growth, J. Neurosci., 18, 9858, 10.1523/JNEUROSCI.18-23-09858.1998 Pareek, 2006, Cyclin-dependent kinase 5 activity regulates pain signaling, Proc. Natl. Acad. Sci. U S A, 103, 791, 10.1073/pnas.0510405103 Pareek, 2006, Cdk5: A new player in pain signaling, Cell Cycle, 5, 585, 10.4161/cc.5.6.2578 Peng, 2009, Estrogen-dependent facilitation on spinal reflex potentiation involves the Cdk5/ERK1/2/NR2B cascade in anesthetized rats, Am. J. Physiol. Endocrinol. Metab., 297, E416, 10.1152/ajpendo.00129.2009 Peng, 2009, Colon mustard oil instillation induced cross-organ reflex sensitization on the pelvic-urethra reflex activity in rats, Pain, 142, 75, 10.1016/j.pain.2008.11.017 Ren, 2012, Intrathecal injection of metabotropic glutamate receptor subtype 3 and 5 agonist/antagonist attenuates bone cancer pain by inhibition of spinal astrocyte activation in a mouse model, Anesthesiology, 116, 122, 10.1097/ALN.0b013e31823de68d Rivlin, 1977, Objective clinical assessment of motor function after experimental spinal cord injury in the rat, J. Neurosurg., 47, 577, 10.3171/jns.1977.47.4.0577 Rostas, 1996, Enhanced tyrosine phosphorylation of the 2B subunit of the N-methyl-d-aspartate receptor in long-term potentiation, Proc. Natl. Acad. Sci. U S A, 93, 10452, 10.1073/pnas.93.19.10452 Schroder, 2009, Allosteric modulation of metabotropic glutamate receptor 5 affects phosphorylation, internalization, and desensitization of the micro-opioid receptor, Neuropharmacology, 56, 768, 10.1016/j.neuropharm.2008.12.010 Senderowicz, 2003, Novel small molecule cyclin-dependent kinases modulators in human clinical trials, Cancer Biol. Ther., 2, S84, 10.4161/cbt.207 Singler, 2007, Modulation of remifentanil-induced postinfusion hyperalgesia by propofol, Anesth. Analg., 104, 1397, 10.1213/01.ane.0000261305.22324.f3 Utreras, 2011, Resveratrol inhibits Cdk5 activity through regulation of p35 expression, Mol. Pain, 7, 49, 10.1186/1744-8069-7-49 Wang, 2005, Intrathecal administration of roscovitine inhibits Cdk5 activity and attenuates formalin induced nociceptive response in rats, Acta Pharmacol. Sin., 26, 46, 10.1111/j.1745-7254.2005.00007.x Wang, 2003, Cdk5 activation induces hippocampal CA1 cell death by directly phosphorylating NMDA receptors, Nat. Neurosci., 6, 1039, 10.1038/nn1119 Wei, 2005, Control of cyclin-dependent kinase 5 (Cdk5) activity by glutamatergic regulation of p35 stability, J. Neurochem., 93, 502, 10.1111/j.1471-4159.2005.03058.x Woolf, 1991, The induction and maintenance of central sensitization is dependent on N-methyl-d-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states, Pain, 44, 293, 10.1016/0304-3959(91)90100-C Yang, 2007, Activation of cyclin-dependent kinase 5 (Cdk5) in primary sensory and dorsal horn neurons by peripheral inflammation contributes to heat hyperalgesia, Pain, 127, 109, 10.1016/j.pain.2006.08.008 Zhang, 2012, Intrathecal administration of roscovitine attenuates cancer pain and inhibits the expression of NMDA receptor 2B subunit mRNA, Pharmacol. Biochem. Behav., 102, 139, 10.1016/j.pbb.2012.03.025 Zhao, 2008, Enhancement of spinal N-methyl-d-aspartate receptor function by remifentanil action at delta-opioid receptors as a mechanism for acute opioid-induced hyperalgesia or tolerance, Anesthesiology, 109, 308, 10.1097/ALN.0b013e31817f4c5d Zhao, 2012, Chronic opioid potentiates presynaptic but impairs postsynaptic N-methyl-d-aspartic acid receptor activity in spinal cords: implications for opioid hyperalgesia and tolerance, J. Biol. Chem., 287, 25073, 10.1074/jbc.M112.378737 Zimmermann, 1983, Ethical guidelines for investigations of experimental pain in conscious animals, Pain, 16, 109, 10.1016/0304-3959(83)90201-4